GHO Capital announces final close of Fund IV with over €2.5bn of capital to continue investing in its strategy of driving better, faster and more accessible healthcare GHO Capital Updates GHO Capital announces final close of Fund IV with over €2.5bn of capital to continue investing in its strategy of driving better, faster and more accessible healthcare
GHO Capital acquires Scientist.com, the leading AI-powered R&D orchestration platform Portfolio Company Updates GHO Capital acquires Scientist.com, the leading AI-powered R&D orchestration platform
ELIQUENT Life Sciences acquires Azzur Consulting strengthening Full-Service Quality & Compliance Capabilities ELIQUENT Life Sciences ELIQUENT Life Sciences acquires Azzur Consulting strengthening Full-Service Quality & Compliance Capabilities
ELIQUENT Life Sciences Announces Strategic Acquisition of Leading Pharmacovigilance Firm Truliant Consulting ELIQUENT Life Sciences ELIQUENT Life Sciences Announces Strategic Acquisition of Leading Pharmacovigilance Firm Truliant Consulting
FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility FairJourney Biologics FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility
Jan De Witte joins GHO Capital as Operating Partner GHO Capital Updates Jan De Witte joins GHO Capital as Operating Partner
BioAgilytix to acquire Australia-based 360biolabs® and US-based MicroConstants, to advance its global expansion BioAgilytix BioAgilytix to acquire Australia-based 360biolabs® and US-based MicroConstants, to advance its global expansion
Velocity Clinical Research strengthens management team amid European expansion Velocity Clinical Research Velocity Clinical Research strengthens management team amid European expansion
GHO Capital announces final close of Fund III with over €2 billion of capital to invest GHO Capital Updates GHO Capital announces final close of Fund III with over €2 billion of capital to invest
Velocity Clinical Research not slowing down, buying two new US sites amid own acquisition Velocity Clinical Research Velocity Clinical Research not slowing down, buying two new US sites amid own acquisition
Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands Ardena Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands
Two Labs, an Envision Pharma Group company acquires Riparian Envision Pharma Group Two Labs, an Envision Pharma Group company acquires Riparian
GHO Capital announces the sale of DNA Diagnostics Center to Eurofins DDC GHO Capital announces the sale of DNA Diagnostics Center to Eurofins
Validant acquires Greenleaf Health, leading FDA regulatory consulting firm ELIQUENT Life Sciences Validant acquires Greenleaf Health, leading FDA regulatory consulting firm
Validant acquires Oriel STAT A MATRIX, a global consultancy and training firm for the medical device industry ELIQUENT Life Sciences Validant acquires Oriel STAT A MATRIX, a global consultancy and training firm for the medical device industry
GHO Capital acquires Velocity Clinical Research, signalling evolution of clinical trial site industry Velocity Clinical Research GHO Capital acquires Velocity Clinical Research, signalling evolution of clinical trial site industry
Sterling Pharma Solutions acquires ADC Bio Sterling Pharma Solutions Sterling Pharma Solutions acquires ADC Bio
Envision Pharma Group acquires doDOC to enable seamless document collaboration as part of iEnvision, its global medical affairs platform Envision Pharma Group Envision Pharma Group acquires doDOC to enable seamless document collaboration as part of iEnvision, its global medical affairs platform
